Literature DB >> 26885148

Stent-assisted mechanical recanalization for symptomatic subacute or chronic middle cerebral artery occlusion.

Dong Guo1, Ji Ma1, Teng-Fei Li1, Ming Zhu1, Xin-Wei Han1, Shao-Feng Shui1.   

Abstract

To assess the feasibility and short-term effects of treating patients with subacute or chronic middle cerebral artery (M1) occlusion by stent-assisted mechanical recanalization. Six patients with cerebral arteries occlusion underwent surgery. Six cerebral arteries occlusion in 5 patients were successfully recanalized. On postoperative day 1, four patients' symptoms were relieved and two patients' symptoms were exacerbated, of which one was significantly improved after 3 days, the other one's symptoms were recovered to preoperative levels in 2 weeks. No patients died after surgery. No stroke or transient ischemic attack occurred. The average follow-up of was 4.2 months, no worsening of condition, recurrence or death occurred. The results indicate that for patients with subacute or chronic middle cerebral artery (M1) occlusion, mechanical recanalization was technically feasible under the premise of strict case screening. Mechanical recanalization is able to improve ischemic symptoms and promote dysfunction restoration. But its long-term effect remains to be evaluated by further large samples, long-term follow-up studies.

Entities:  

Keywords:  Middle cerebral artery; mechanical recanalization; occlusion; stent

Year:  2015        PMID: 26885148      PMCID: PMC4723994     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  2 in total

1.  Vascular lesions in Chinese patients with transient ischemic attacks.

Authors:  Y N Huang; S Gao; S W Li; Y Huang; J F Li; K S Wong; R Kay
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

2.  Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke.

Authors:  Mervyn D I Vergouwen; Frank L Silver; Daniel M Mandell; David J Mikulis; Richard H Swartz
Journal:  Arch Neurol       Date:  2011-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.